Get started
Author

Yong Zhang

Targeting FGFR with Dovitinib (TKI258): Preclinical and Clinical Data in Breast Cancer
2013 · Fabrice André, Thomas Bachelot, et al. · Clinical Cancer Research · 317
Phase II, randomized, placebo-controlled study of dovitinib in combination with fulvestrant in postmenopausal patients with HR+, HER2− breast cancer that had progressed during or after prior endocrine therapy
2017 · Antonino Musolino, Mario Campone, et al. · Breast Cancer Research · 114
PDF
FBW7 loss promotes epithelial-to-mesenchymal transition in non-small cell lung cancer through the stabilization of Snail protein
2018 · Yong Zhang, Xinxin Zhang, et al. · Cancer Letters · 62
PDF
Targeting FBW7 as a Strategy to Overcome Resistance to Targeted Therapy in Non–Small Cell Lung Cancer
2017 · Mingxiang Ye, Yong Zhang, et al. · Cancer Research · 58
Loss of NDRG2 in liver microenvironment inhibits cancer liver metastasis by regulating tumor associate macrophages polarization
2018 · Mengyang Li, Xiaofeng Lai, et al. · Cell Death and Disease · 54
PDF
The Down-Regulation of Notch1 Inhibits the Invasion and Migration of Hepatocellular Carcinoma Cells by Inactivating the Cyclooxygenase-2/Snail/E-cadherin Pathway In Vitro
2012 · Liang Zhou, De-sheng Wang, et al. · Digestive Diseases and Sciences · 45
Up‐regulated basigin‐2 in microglia induced by hypoxia promotes retinal angiogenesis
2017 · Jie Yin, Wen‐Qin Xu, et al. · Journal of Cellular and Molecular Medicine · 42
PDF
Bakuchiol Protects Against Acute Lung Injury in Septic Mice
2016 · Xinxin Zhang, Ning Chang, et al. · Inflammation · 37
miR-24-3p/FGFR3 Signaling as a Novel Axis Is Involved in Epithelial-Mesenchymal Transition and Regulates Lung Adenocarcinoma Progression
2018 · Pengyu Jing, Nan Zhao, et al. · Journal of Immunology Research · 29
PDF
Recent Insight on Regulations of FBXW7 and Its Role in Immunotherapy
2022 · Liangliang Xing, Leidi Xu, et al. · Frontiers in Oncology · 27
PDF
LTBR acts as a novel immune checkpoint of tumor‐associated macrophages for cancer immunotherapy
2024 · Liang Wang, Jieyi Fan, et al. · iMeta · 25
PDF
Alterations of lower respiratory tract microbiome and short-chain fatty acids in different segments in lung cancer: a multiomics analysis
2023 · Yong Zhang, Xiangxiang Chen, et al. · Frontiers in Cellular and Infection Microbiology · 23
The up-regulation of cysteine-rich protein 61 induced by transforming growth factor beta enhances osteosarcoma cell migration
2013 · Jun Chen, Yang Song, et al. · Molecular and Cellular Biochemistry · 21
miR‑628 reduces prostate cancer proliferation and invasion via the FGFR2 signaling pathway
2019 · Jun Chen, Peng Hao, et al. · Experimental and Therapeutic Medicine · 17
PDF
Tanshinone IIA attenuates epithelial–mesenchymal transition to inhibit the tracheal narrowing
2016 · Hongtao Duan, Lijie Ma, et al. · Journal of Surgical Research · 11
Enhanced antitumor immunity of nanoliposome-encapsulated heat shock protein 70 peptide complex derived from dendritic tumor fusion cells
2015 · YUNFEI ZHANG, WEN LUO, et al. · Oncology Reports · 11
PDF
Acetate-producing bacterium Paenibacillus odorifer hampers lung cancer growth in lower respiratory tract: an in vitro study
2024 · Xiang-xiang Chen, Dan Qiu, et al. · Microbiology Spectrum · 8
Localization of FGF21 Protein and Lipid Metabolism-Related Genes in Camels
2023 · Yuan Gao, Shuqin Zhao, et al. · Life · 8
PDF
Efgartigimod therapy for immune checkpoint inhibitor–associated myasthenia gravis with myositis: a case report
2025 · Feiteng Qi, Qi Sun, et al. · BMC Neurology · 4
Phase II study of the multikinase inhibitor dovitinib (TKI258) or placebo in combination with fulvestrant in postmenopausal, endocrine resistant HER2-/HR+ breast cancer.
2012 · Fabrice Andre, Richard Greil, et al. · Journal of Clinical Oncology · 1
Supplementary Figure Legend, Table 1 from Targeting FGFR with Dovitinib (TKI258): Preclinical and Clinical Data in Breast Cancer
2023 · Fabrice André, Thomas Bachelot, et al.
Supplementary Figure 1 from Targeting FGFR with Dovitinib (TKI258): Preclinical and Clinical Data in Breast Cancer
2023 · Fabrice André, Thomas Bachelot, et al.
PDF
Data from Targeting FGFR with Dovitinib (TKI258): Preclinical and Clinical Data in Breast Cancer
2023 · Fabrice André, Thomas Bachelot, et al.
Data from Targeting FGFR with Dovitinib (TKI258): Preclinical and Clinical Data in Breast Cancer
2023 · Fabrice André, Thomas Bachelot, et al.
An open-label, randomized phase II study comparing first-line treatment with dovitinib (TKI258) versus sorafenib in patients with advanced hepatocellular carcinoma.
2012 · Ann-Lii Cheng, Ho Yeong Lim, et al. · Journal of Clinical Oncology
Works count: 25
Citation count: 914
H-index: 14
I10-index: 16
Year
Topic
Type